Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Clin Ter ; 147(12): 609-20, 1996 Dec.
Article in Italian | MEDLINE | ID: mdl-9296920

ABSTRACT

We studied 20 patients suffering from rheumatoid arthritis treated with small doses of sodium aurothiomalate (20 mg/month, seldom 40 mg/month) for a mean time of 6.1 years (range 2.7-10.6). 16 subjects were women and 4 men; their mean age was 58 years (range 35-77). 9 patients (45%) were affected by seropositive RA; the mean duration of disease was 1.5 years (range 0.3-7.3). 14 patients achieved the grade 1 of disease activity, evaluated by Mallya and Mace's (1981) criteria: 9 subjects after 3-9 months and 5 subjects after 2-5 years. The mean length of this remission state was 4.3 years (range 0.9-9.9). Side dermatological effects (skin rashes, pruritus, exfoliative dermatitis) were observed in 3 patients (15%); 1 patient (5%) was withdrawn from the study. We have discussed the numerous advantages of low doses of sodium aurothiomalate monotherapy, although this therapy has to be employed only in patients selected by prognostic features. Moreover we briefly mention the actual opinions in R.A. therapy that discuss the traditional pyramidal approach in favour of more aggressive therapy with combination of various disease-modifying drugs in many R.A. patients.


Subject(s)
Antirheumatic Agents/administration & dosage , Arthritis, Rheumatoid/drug therapy , Gold Sodium Thiomalate/administration & dosage , Adult , Aged , Antirheumatic Agents/adverse effects , Drug Evaluation , Female , Gold Sodium Thiomalate/adverse effects , Humans , Male , Middle Aged , Remission Induction , Time Factors
3.
Clin Rheumatol ; 9(1): 51-5, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2159392

ABSTRACT

In twelve rheumatoid arthritis (RA) patients, receiving only nonsteroid anti-inflammatory therapy, superoxide anion (02-) generation by polymorphonuclear leucocytes (PMNs) was assessed by Cytochrome C reduction. The 02- production by non-activated PMNs in RA patients was significantly higher than in healthy controls. The 02- production by PMNs activated by zymosan and phorbol myristate acetate was significantly lower than in controls. PMNs from controls preincubated with rheumatoid sera generated higher 02- levels than the same PMNs incubated in normal sera.


Subject(s)
Arthritis, Rheumatoid/blood , Neutrophils/metabolism , Superoxides/metabolism , Adult , Aged , Arthritis, Rheumatoid/metabolism , Cytochrome c Group/metabolism , Female , Hot Temperature , Humans , Male , Middle Aged , Neutrophils/physiology , Osteoarthritis/blood , Osteoarthritis/metabolism , Oxidation-Reduction , Superoxide Dismutase/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Zymosan/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...